EU approves AZ's Imfinzi plus chemo for advanced biliary tract cancer AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the European Union (EU) as first-line treatment of adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback